MedTrace Logo

Moxifloxacin vs. Polytrim for Conjunctivitis

NCT00581542 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2016-01-18

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.

Conditions

Interventions

DRUG

moxifloxacin

1-2 drops three times a day for 8-10 days.

DRUG

polytrim

1-2 drops four times a day for 8-10 days.

Sponsors & Collaborators

  • University of Rochester

    lead OTHER

Principal Investigators

  • Francis Gigliotti, MD · University of Rochester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Year
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00581542 on ClinicalTrials.gov